World class operating partners with hundreds of years of collective experience scaling businesses across the healthcare, consumer and technology industries.
Former CEO of Liz Claiborne, Inc. and led the transformation to Kate Spade & Company in 2014; Former Company Group Chairman for DePuy Orthopedics within Johnson & Johnson; Former President of McNeil Consumer Healthcare
Mr. McComb has spent his career building and growing global brands. Most recently, Mr. McComb served as Chief Executive Officer of Kate Spade (formerly Liz Claiborne, Inc). Previously, Mr. McComb spent 14 years at Johnson & Johnson where his leadership roles included Company Group Chairman for DePuy Orthopaedics and President of McNeil Consumer Healthcare. Mr. McComb sits on the on the Board of Intrinsic’s breathalyzer technology portfolio company, Hound Labs, and serves as Non-Executive Chairman of Intrinsic’s hemp-derived consumer healthcare portfolio company, NextEvo.
Former CEO of Kraft Foods; Former Company Group Chairman for DePuy Orthopedics within Johnson & Johnson; Former President of McNeil Consumer Healthcare; Former President, Centocor Biologics
Mr. Vernon has spent his career building and growing healthcare and CPG companies and global brands, including PEPCID AC, TYLENOL, and KRAFT FOODS products. In addition, Mr. Vernon spent three years as Health Care Industry Partner at Ripplewood Holdings, LLC. Mr. Vernon provides strategic guidance and advice across Intrinsic’s portfolio companies and prospective investment opportunities.
Former Global Head of Supply Chain across multiple divisions within Johnson & Johnson, including Global Biologics and Jansen; Former WWVP of Quality at Warner Lambert (Pfizer)
Mr. Sheroff is a supply-chain expert who has run multi-billion-dollar operations. Most notably, Mr. Sheroff was Head of Supply Chain for large divisions within Johnson & Johnson, including Global Biologics and Jansen. Mr. Sheroff sits on the Board of Intrinsic’s lab testing portfolio company, ACT Labs, and serves as an Advisor to NextEvo.
Former Commercial Executive within Johnson & Johnson; Former Global Head of One Touch Hospital Blood Glucose Monitoring Business; Former Head of TYLENOL Franchise at Johnson & Johnson
Mr. McDonagh has over 25 years of commercial healthcare leadership across consumer, medical device, and pharmaceutical business models. Mr. McDonagh was responsible for launching and growing key Johnson & Johnson brands such as TYLENOL, PEPCID AC and CONCERTA. Mr. McDonagh is the Chief Executive Officer of NextEvo and consults on ACT Labs’ commercial strategy.
Former Head of R&D and Product Development at Johnson & Johnson Consumer and McNeil Consumer Healthcare
Dr. McNally was previously the head of R&D and product development at Johnson & Johnson Consumer and McNeil Consumer Healthcare during a career spanning more than 25 years. Dr. McNally is the Vice President of Research & Development for NextEvo.
Former Director, DDMAC of the FDA; Former Natl. Health Fraud Coord. of the FDA; Former WWVP of Reg. Affairs for Medical Devices & Diagnostics within Johnson & Johnson; Former VP of Medical & Reg. Affairs for McNeil Consumer Healthcare
Ms. Baylor Henry has spent her career in medical regulatory affairs. Her roles have included Worldwide Vice President of Regulatory Affairs for Medical Devices & Diagnostics at Johnson & Johnson, as well as senior roles at the U.S. Food and Drug Administration, including National Health Fraud Coordinator and Director of the Division of Drug Marketing, Advertising, and Communications. Ms. Baylor Henry serves as an Advisor to NextEvo.
Former SVP Gilead Sciences Inc; Former Head of Quality across multiple divisions of Johnson & Johnson
Most recently serving as the Senior Vice President of Quality at Gilead Sciences Inc., Dr. Miller has a wealth of experience in the design and implementation of quality systems and guiding companies that are actively engaged in quality and compliance efforts in response to the FDA and other global regulatory agencies. Working with major global healthcare companies, Dr. Miller gained deep experience in diverse product portfolios, including solid and liquid dosage forms, API’s, Rx and over-the-counter products. Dr. Miller is the current Chief Operating Officer of ACT Labs and serves as a Scientific Advisor to NextEvo.
Executive Committee Member & Senior Managing Director of FS Investments; Former Corporate and Securities Council; Former State Legislator
Since 2012, Mr. Gerber has served as a top executive at FS Investments. As Executive Vice President of Administration, Communication and Public Affairs at FS Investments, Mr. Gerber manages firm administration, human resources, communications and the firm’s government affairs, regulatory and policy team and serves on the firm’s Executive Committee. Prior to joining FS Investments, Mr. Gerber practiced corporate and securities law at Drinker Biddle & Reath LLP. He previously served eight years in the Pennsylvania House of Representatives and six years as a trustee of Pennsylvania’s State Employees’ Retirement System, where he was a member of the Audit and Investment Committees.
Former Intellectual Property Lawyer at Pennie & Edmonds and Sidley Austin
Mr. Lawrence spent over 45 years practicing intellectual property law at Pennie & Edmonds and Sidley Austin where he represented top firms in the pharmaceutical, biotechnology and chemical industries. Mr. Lawrence provides Intrinsic with valuable intellectual property insight across prospective investment opportunities and existing portfolio companies.